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Recent studies have demonstrated biased usage of TCR Vb17 and a high degree of diversity in Jb usage within the
influenza virus matrix epitope (M.58-66)-specific CTL response. In contrast, in the course of a study on the cellular response
to influenza A virus, we found preferential usage of Vb17-Jb2.2 rearrangement in an individual with an unexpectedly high
number of CTL precursors (CTLp). We took advantage of such situation to study the longitudinal repertoire of the CD8/ T
cell precursors. By limiting dilution analysis combined with the use of a clonotypic primer corresponding to the CDR3 region
of this matrix-specific TCR Vb chain, the influenza-specific CTLp were shown to be stable for a period of 5 years. Overall,
our results show that virus-specific CTLp can be directly monitored in vivo by molecular fingerprinting without in vitro
restimulation. These findings might be extremely important for evaluation of the specific immune response to a given human
pathogen. q 1997 Academic Press
INTRODUCTION enza A virus CTL precursors (CTLp) specific for the influ-
enza matrix-encoded epitope M.58-66. A clonotypic
Cytotoxic T lymphocytes (CTLs) recognize virus-in- primer corresponding to the CDR3 region of the major
fected cells via an a/b heterodimeric membrane receptor matrix-specific TCR Vb chain was then used to monitor
(TCR) with specificity for peptide antigen presented by the longitudinal repertoire of the influenza-specific CTLp
class I MHC molecules. The TCR is composed of V, D, response on lymphocytes isolated directly from periph-
J, and C regions encoded in gene segments that undergo eral blood.
genetic mechanisms of diversification. The region in
which addition of non-germ-line-encoded nucleotides
MATERIALS AND METHODStakes place during these joining events, defines the
CDR3, which is involved in antigen specificity (Davis and
Lymphocyte donors
Bjorkman, 1988). Studies of the T-cell response during
an immune response or to virus infection have been per- Lymphocytes from donors HC12 and DO were used
formed mainly with T cell clones or T cell lines isolated for this study. Several PBMC samples from donor HC12
after in vitro restimulation, where culture condition can were analyzed over a period of 3 years (1992–1994). HLA
favor the emergence of a skewed repertoire. Only re- serotyping of HC12 PBMC was performed at the Centre
cently single-cell PCR analysis has been used to study National de Transfusion Sanguine (Paris, France) and
the kinetics of an antigen-selected TCR repertoire in im- the HLA type was A2/3, B7/60, C7/-, and DR4/8. The HLA-
mune mice directly on lymphocytes isolated from periph- A0201 type was determined in our laboratory by cellular
eral blood (Maryanski et al., 1996). Experiments using typing. PBMC were isolated from a Ficoll density gradient
PCR monitoring of PBMCs ex vivo have also demon- (Lymphocyte separation medium, Flow laboratories,
strated a long-term maintenance and expansion of the Scotland) and stored frozen in liquid nitrogen.
primary anti-EBV-specific memory response during the
course of primary EBV infection (Silins et al., 1996).
Virus and peptides
The present report analyzes the influenza virus-spe-
cific T cell response in an HLA-A0201/ individual. This Influenza virus strains A/Bangkok (A/Ban), B/Yama-
was done by determining the TCR-b sequences of influ- moto (B/Yama), and B/Singapore (B/Sin) were grown in
the allantoic cavity of embryonated chicken eggs. They
were prepared by Dr. C. Hannoun (Institut Pasteur, Paris).1 To whom correspondence and reprint requests should be ad-
Synthetic peptides M.58-66 and NP.335-349 were deriveddressed. Fax: 33 01 44 07 14 25. E-mail: armelle.prevost-blondel@icgm.
cochin.inserm.fr. from amino acid sequences of the influenza A virus ma-
93
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8604 / 6a37$$$501 05-22-97 08:34:58 vira AP: Virology
94 PREVOST-BLONDEL ET AL.
trix and nucleoprotein proteins and were synthesized by gated Leu 2a mAb. The mAb specific for the TCR Vb17
gene product was generously provided by Dr. A. Diu (DiuNeosystem (Strasbourg, France).
et al., 1993). Cells were incubated with antibodies for 30
Generation of influenza A virus and peptide M.58-66- min at 47, washed twice, and analyzed on an Epics profile
specific CTL analyzer (Coulter Corp., Hialeah, FL).
CTL lines specific for influenza A virus or for the matrix
peptide were generated from PBMC of donor HC12 as Oligonucleotide TCR primer
described previously (Martinon et al., 1990), using weekly
The 24 TCR Vb subfamily-specific, CbC- and CbD-in vitro stimulation with autologous irradiated cells in-
specific, and CaE- and CaJR-specific oligonucleotidefected with 10 hemagglutination (HA) units of influenza
primers were characterized (Geneve´e et al., 1992). TheA/Ban virus per 106 cells or preincubated with 0.1 mM
Jb-specific primers have been described elsewhere (Pui-matrix peptide. The effector cells were harvested after 1,
sieux et al., 1994). A primer specific for the CDR3 region2, or 3 weeks in culture.
of the predominant Vb17-Jb2.2 rearrangement selected
in response to the influenza virus in the donor HC12Chromium release test
was designed. The sequence of this antisense clonotypic
CTL activity was assayed by a chromium release test primer is TCATCGGAGGCCCGCTGG, and its hybridiza-
using autologous EBV-transformed lymphoblastoid cell tion temperature was 627. The CbD, CaJR, Jb, and clono-
lines as target cells. They were prepared as previously typic-specific primers were labeled with an Applied Bio-
described (Martinon et al., 1990) by infection with influ- systems fluorophore (Fam, Joe, Rox or Tamra) by Geno-
enza virus (20 HA units per 106 cells) or by incubation sys (Genosys Biotechnologies Inc., Cambridge, UK).
with 0.1 mM peptide.
mRNA extraction, cDNA synthesis, and PCRLimiting dilution analysis (LDA)
amplification
The frequency of CTLp was analyzed by LDA, per-
formed as previously described (Bourgault et al., 1989). Total RNA was extracted from 5–10 1 106 cells with
Briefly, PBMC were seeded in limiting numbers in 96- guanidium isothiocyanate followed by centrifugation in
well round-bottomed plates containing 3 1 104 A/Ban cesium chloride (Glisin et al., 1974). RNA was extracted
virus-infected irradiated (4000 rad) autologous PBMC as with phenol:chloroform, precipitated with ethanol, and
stimulating cells and feeder cells in 0.2 ml of culture stored in water. The RNA concentrations were deter-
medium. PBMC dilutions varied from 10,000–1,250 cells/ mined by optical density. Five micrograms of RNA were
well. Forty-eight replicates were set up for each re- reverse-transcribed into cDNA using the Boehringer-
sponder concentration. Subsequently, 10 U/ml of recom- Mannheim cDNA synthesis kit and oligo(dT) (Boehringer-
binant human IL2 (Boehringer Mannheim Corp., Mann- Mannheim Corp., Mannheim, Germany). The solution
heim, Germany) was added every 3 days. After 14 days was incubated for 1 hr at 427 and for 10 min at 527.
of culture, 24 replicates for each responder concentration Aliquots corresponding to 100 ng total mRNA were
were tested for cytotoxic activity against B-EBV target amplified in a 50-ml reaction volume with a primer set
cells incubated or not with M.58-66 peptide. The other (Vb and Cb hybridizing to sense and antisense strands,
24 replicates were tested for cytotoxic activity against B- respectively). The unlabeled PCR reaction included the
EBV target cells incubated with the A/Ban virus or with cDNA (or water in negative controls), 0.25 mM Cb primer,
the B/Yama virus. The specific lysis for each well was 1.5 mM MgCl2 , 50 mM KCl, 10 mM Tris–HCl, 160 mM
calculated from the formula (cpm-RS/RT-RS): Each well dNTP, 1.25 units of Taq polymerase (Promega Corp.,
was considered to be positive if specific lysis was greater Madison, WI), and 0.25 mM Vb-specific primer. Amplifica-
than 10%. This threshold value was always greater than tions used an initial 3-min denaturation step at 947 fol-
the mean plus 3 standard deviation of the spontaneous lowed by 40 cycles (1-min denaturation at 947, 1.5-min
chromium release. annealing at 607, and 2-min polymerization at 727) in a
DNA thermocycler (Perkin–Elmer–Cetus Corp., Norwalk,
Cell phenotype analysis
CT; model 9600). Directly labeled PCR reactions were
carried out with the cDNA, 0.25 mM fluorescent clono-The CD8/ population was estimated using phycoer-
typic, or Jb2.2-specific primer, 1.5 mM MgCl2 , 50 mMythrin (PE)-conjugated Leu 2a mAb (Becton–Dickinson,
KCl, 10 mM Tris–HCl, 160 mM dNTP, 1.25 units of TaqSan Jose, CA). The Vb17/CD8 population was analyzed
polymerase (Promega), 0.25 mM Vb17-specific primer,by indirect immunofluorescence using human anti-Vb17
0.025 mM CaE primer, and 0.025 mM CaJR fluorescent(mAb E-17.5F3) antibody, fluorescein isothiocyanate
primer. Cycle parameters were 1 min at 947, 1.5 min at(FITC)-conjugated goat anti-mouse F(ab*)2 (Diagnostic
Pasteur, Marne la Coquette, France), and then PE-conju- 627, and 1.5 min at 727 for 20 cycles.
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FIG. 1. Cytolytic activity of influenza-specific cell lines. T cell lines were generated from HC12 PBMC by stimulation with M.58.66 peptide (A) or
A/Ban virus (B) as described under Materials and Methods. Their cytotoxic activity was assayed against autologous target cells incubated with
M.58-66 or NP.335-349 peptide, or infected with A/Ban or B/Sin virus.
Labeling reaction, electrophoresis, and data analysis RESULTS
Unlabeled amplified products were mixed with 1 mM Pattern of cytotoxic activity of influenza-specific T-cell
CbD or Jb-specific labeled primer as previously de- lines
scribed (Pre´vost-Blondel et al., 1995). The primer exten-
sion reaction started with denaturation for 1 min at 947, A T-cell line from an HC12 PBMC sample from 1992
followed by 1 min at 607, and 1.5 min at 727 for 5 cycles. was first generated by two in vitro stimulations with influ-
The direct fluorescent PCR products and primer exten- enza virus matrix peptide M.58-66. This line presented
sion reaction products were heat-denatured at 807 in 5 specific cytotoxic activity against autologous target cells
ml 95% formamide–10 mM EDTA and loaded onto a 6% sensitized with peptide M.58-66, but not with the irrele-
acrylamide 8 M urea gel together with size standards vant influenza peptide NP.335-349 (Fig. 1A). These CTL
(Genescan-2500 Rox markers, Applied Biosystems, Inc., were able to recognize the natural epitope after infection
Foster City, CA). The gel was electrophoresed at 1200 V of target cells with A/Ban but not with B/Sin virus. Cyto-
for 8 hr on an Applied Biosystems 373A DNA sequencer lytic activity against the M.58-66 peptide was HLA-A0201-
(Applied Biosystems., Foster City, CA). Data were pro- restricted, since only HLA-A0201 allogeneic target cells
cessed using specific software (Pannetier et al., 1993) were lysed (data not shown).
and graphed. The expression percentage of each Vb17- In addition, a T-cell line was generated from the same
Jb rearrangement was plotted as a function of CDR3 HC12 PBMC sample by two in vitro stimulations with
length for each PCR product. influenza A/Ban virus. The results were in agreement
with those previously described (Martinon et al., 1990),
Cloning and sequencing since cytotoxic activity was observed against autologous
target cells infected with A/Ban virus or incubated withPCR products were purified in 1% low-melting point aga-
peptide M.58-66 (Fig. 1B). There was no significant re-rose gel, phosphorylated with T4 polynucleotide kinase,
sponse to uninfected cells, cells sensitized by B/Sin vi-and ligated to SmaI-digested and dephosphorylated M13
rus, or cells incubated with peptide NP.335-349. Thismp18 RF vector. Escherichia coli strain TG1 was trans-
confirms the immunodominant recognition of matrix pep-formed, and white plaques from IPTG/XGal plates were
tide M.58-66 by HLA-A0201 donors as previously de-sequenced by the Sanger dideoxy method adapted to the
ABI 373A automated sequencer (Sanger et al., 1977). scribed (Bednarek et al., 1991).
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FIG. 2. Frequency of influenza-specific CTLp in HC12 PBMC. LDA were performed as described under Materials and Methods. The frequency
of anti M.58-66 peptide CTLp (A) and of anti-influenza A/Ban virus (B). CTLp is estimated from the intercept of the regression line at 37% negative
wells. Upper and lower 95% confidence intervals were calculated by the method of X2 minimization.
High frequency of anti-M.58-66 peptide and anti-A/ was about 10-fold higher than that for the virus. In this
regard, we found that the overall killing rate of A/Ban-Ban virus CTLp in HC12 PBMC
infected target cells was usually lower than that of pep-
LDA were performed to analyze the frequency of M.58-
tide-coated targets.
66 peptide-specific CTLp and influenza A/Ban virus-spe-
cific CTLp from HC12 PBMC samples (1992 and 1994) Longitudinal analysis of TCRb chain expression in
after stimulation with A/Ban virus (Fig. 2). No significant influenza-specific T-cell lines
CTLp frequency was observed against both autologous
noninfected target cells or B/Yama-infected cells (Fig. 2). Clonal analysis was used to monitor modifications in
TCRb chain distribution in HC12 cells before and afterA high frequency of CTLp was detected against autolo-
gous target cells incubated with the M.58-66 peptide (1/ one stimulation with A/Ban virus. Analysis profiles of PCR
products evidenced a single peak from the Vb17 PCR2,125) from the 1992 sample (Fig. 2A). Interestingly, a
similar high frequency (1/2,800) was detected with the product, strongly suggesting oligoclonal expansion after
virus stimulation (data not shown). The emergence of1994 sample. In parallel, the frequency of influenza A
virus-specific CTLp was estimated in the peripheral Vb17 transcripts was confirmed by studying surface Vb
expression with a monoclonal antibody specific for Vb17blood of the HC12 donor in the years 1992 and 1994. A
high frequency of CTLp was also observed against A/ gene products after 1, 2, or 3 stimulations. Vb17/CD8/
T cells accounted for over 80% of the cells after twoBan-infected target cells (1/23,600) from the 1992 sample
and (1/17,800) from the 1994 sample (Fig. 2B). The fre- stimulations with matrix peptide (Fig. 3A) and for 60% of
the cells after one stimulation with the virus (Fig. 3B).quency of CTLp specific for the M58-66 influenza peptide
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clones. Furthermore, we confirmed the oligoclonality of
the Vb17-Jb2.2 rearrangement by sequencing the TCRa
chain junction region of this predominant influenza spe-
cific-clone (the sequence Va10 is not shown).
Longitudinal analysis of TCR Vb17 chain transcripts
in HC12 PBMC
Clonal analysis was then used to monitor the evolution
of TCR Vb17 chain distribution in different samples of
HC12 PBMC and to compare it to another donor, DO.
Figures 4 and 5A–5C show analysis profiles for Vb17
PCR products labeled with CbD and 13 Jb-specific oligo-
nucleotide primers. The peak number is a direct measure
of b chain complexity. This method has the advantage
of providing a relative quantification without cloning and
sequencing. The majority of graphs from PBMC of donor
DO were Gaussian (Fig. 4). This indicates the diversity
of Vb17-Jb rearrangements and reflects the polyclonal
nature of these populations in the peripheral blood of
this donor, as is the case for most normal individuals.
Graphs of the Vb17-Cb PCR product from HC12 PBMC
(1992) had a quasi-Gaussian profile, with a predominant
peak corresponding to rearrangements with a CDR3 re-
gion 8-amino acids long (Fig. 5A). Analysis of each Vb17-
Jb transcript and the normalization of the expression of
each Vb17-Jb combination with the Y-axis scale clearly
showed high expression of the Vb17-Jb2.2 combination
in the PBMC of this donor. Longitudinal analysis of each
Vb17-Jb combination over 3 years showed high expres-
sion of the Vb17-Jb2.2 combination, even though Vb17-
Jb2.2 rearrangements seemed to be more actively ex-
pressed in 1993 (Figs. 5A–5C). The very poor visualiza-
FIG. 3. Vb17 expression during stimulation with the M.58-66 peptide
tion of the other Vb17-Jb combinations was due to theor with A/Ban virus. M.58-66 peptide (A) or influenza A virus-specific
abnormally high frequency of the Vb17-Jb2.2 combina-(B) T cells were stained with human anti-Vb17 and FITC-conjugated
goat anti-mouse F(ab*)2 and then with PE-conjugated Leu 2a mAb. tion in this donor. We decided to normalize the expres-
sion of each combination with the Y-axis scale (percent-
Analysis of influenza-specific molecular clones age expression). Thus, the more the combination of the
Vb17-Jb2.2 was expressed, the more difficult it was toVb17 PCR fragments of the M.58-66 peptide-specific
visualize the other Vb17-Jb combinations. For example,T-cell line were cloned and sequenced. The predicted
it was easier to detect the different transcripts on Fig.amino acid sequences are shown in Table 1. Three
5A than those on Fig. 5C, and those on Fig. 5C than onVb17-Jb combinations were obtained after two stimula-
Fig. 5B. However, analysis of Vb17 chain transcripts fromtions (Table 1A). Clone P1 expressed the Jb1.6 gene
another donor (Fig. 4) clearly illustrates that almost allsegment and clone P2 the Jb1.1 segment. Clones P3,
Vb17-Jb combinations can be detected, particularly theP4, and P5 had Vb17-Jb2.2 rearrangements. Only the
Vb17-Jb2.1 and the Vb17-Jb2.7, which are expressedVb17-Jb2.2 combination was found after three stimula-
with a high frequency.tions (Table 1B). The Vb17 clone had a CDR3 region 8
A PCR was run with the Vb17 primer and the Jb2.2amino acids (aa) long, as measured from aa 95 of the
fluorescent primer to more accurately quantify Vb17-Jb2.2Vb17 gene segment to aa 106 of the Jb2.2 segment.
rearrangements over the 3 years. We coamplified the CaE-Sequencing of the Vb17 PCR products after 1 and 3
CaJR fluorescent product. The fluorescence intensity ratiovirus stimulations revealed a predominant clone. It corre-
for the Vb17-Jb2.2 fragment and the CaE-CaJR fragmentsponded to the Vb17-Jb2.2 rearrangement having a
was used to estimate the expression of Vb17-Jb2.2 tran-CDR3 8 amino acids long (Tables 1C and 1D). The CDR3
scripts (Fig. 6A). The relative stability of Vb17-Jb2.2 rear-nucleic acid sequence was identical to that previously
identified for the M.58-66-specific T-cell line molecular rangements over time was therefore confirmed.
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TABLE 1
Analysis of M58-66 Peptide and Influenza A Virus-Specific T Cell Lines
CDR3
Clones Vb 92 NDbN 107 Jb length
(A) After two stimulations with the M58-66 matrix peptide
P1 17 TGT GCC AGT AGT ATC GGC ATT AAT TCA CCC CTC CAC 1.6 8
CYS ALA SER SER ILE GLY ILE ASN SER PRO LEU HIS
P2 17 TGT GCC ACT CTT ACA GGG TCG GGA TTG AAC ACT GAA GCT TTC 1.1 10
CYS ALA THR LEU THR GLY SER GLY LEU ASN THR GLU ALA PHE
P3 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
P4 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
P5 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
CYS ALA SER SER LEU ARG ALA THR GLY GLU LEU PHE
(B) After three stimulations with the M58-66 matrix peptide
P6 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
P7 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
CYS ALA SER SER LEU ARG ALA THR GLY GLU LEU PHE
(C) After one stimulation with the influenza A virus
V1 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V2 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V3 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V4 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V5 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
CYS ALA SER SER LEU ARG ALA THR GLY GLU LEU PHE
(D) After three stimulations with the influenza A virus
V6 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V7 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
V8 17 TGT GCC AGT AGC CTC CGG GCG ACC GGG GAG CTG TTT 2.2 8
CYS ALA SER SER LEU ARG ALA THR GLY GLU LEU PHE
Note. Sequences of influenza-specific molecular clones. Vb17 PCR products from matrix peptide-specific T cell line, stimulated 2 (A) and 3 times
(B), were cloned and sequenced. The M.58-66 peptide specific clones were numbered P1-P7. The 92 and 107 positions are in bold letters. The
CDR3 length was measured from position 95 of Vb to position 106 of Jb (Kabat et al., 1991). The nucleic acid sequence was translated into the
amino acid sequence. The amino acid sequence for the same nucleotide sequence is written only once. Underlined residues are those close to
the Moss motif. PCR products from influenza virus-specific T-cell line, stimulated once (C) and 3 times (D) were sequenced. The virus-specific
clones were numbered V1-V8.
Detection of influenza-specific transcripts in donor clonotype fragment and the CaE-CaJR fragment was
used to compare the expression of Vb17-Jb2.2 tran-HC12 PBMC
scripts over the 3-year period (Fig. 6B). This confirmed
The sequence of the predominant influenza virus-spe- the stability of influenza-specific clone expression in
cific molecular clone in donor HC12 allowed us to design HC12 PBMC. This ‘‘relative quantification’’ allowed us to
a clonotypic oligonucleotide specific for its b chain CDR3 show a parallel between the expression of the Vb17-
region. We detected the Vb17-clonotype transcript in Jb2.2 combination and the expression of the clonotype
HC12 PBMC samples over a period of 3 years (1992– specific for the influenza virus over a period of 3 years.
1994), whereas this transcript was not detected in the
DISCUSSIONPBMC of donor DO (data not shown). We also performed
a direct fluorescent PCR with the Vb17 and clonotypic Clonal distribution in the CD8/ T cell population of
normal individuals frequently occurs (Grunewald et al.,primers. The ratio of fluorescence intensities of the Vb17-
FIGS. 4 and 5A–5C. Vb17-Jb rearrangement analysis. Total RNA was extracted from the PBMC of donor DO (Fig. 4) and from the PBMC of donor
HC12 in 1992 (Fig. 5A), 1993 (Fig. 5B), and 1994 (Fig. 5C), and reverse transcribed into cDNA. PCR were performed with CbC and the Vb17-specific
primers. The PCR products, labeled with the fluorescent CbD or with the 13 Jb-specific primers, were separated on a sequencing gel according
to their size. Signals were integrated and data were processed using special software (Pannetier et al., 1993). The graphs show the percentage of
expression of the Vb17-Cb and of each Vb17-Jb combination for each CDR3 size.
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FIG. 6. Quantitation of an influenza-specific clonotype in HC12 PBMC. Total RNA was extracted from PBMC samples over a period of 3 years
and reverse transcribed into cDNA. Direct fluorescent PCR was performed with the Vb17 primer and the Jb2.2 (A) or the clonotypic fluorescent
primer previously designed (see Materials and Methods) (B). CaJR and CaE were added to the reaction for quantification. The graphs show the
fluorescence intensity ratio of Vb17-Jb2.2 and Vb17-clonotype PCR products to CaE-CaJR PCR products as a function of HC12 PBMC samples.
1992; Hingorani et al., 1993; Morley et al., 1995; Posnett al., 1995; Moss et al., 1991). Our TCR analysis of the
M.58-66-specific CTL response from the high responderet al., 1994), but the specificity of these clones is poorly
understood. The present report describes in vivo long- donor revealed a contrasting picture. The same Vb17-
Jb2.2 population was selected in response to both theterm maintenance of dominant CTL precursors directed
against influenza virus M.58-66 T cell epitope. The fre- influenza virus and the cognate matrix peptide. Consider-
ing the wide potential variation in Jb usage, this impliesquency of CTLp specific to the M.58-66 peptide in associ-
ation with the HLA-A0201 molecule was estimated at strong selection for the Vb-Jb region by the HLA-A0201/
M.58-66 peptide complex in this donor. A previous studybetween 1/54,000 and less than 1/250,000 in normal indi-
viduals (Lehner et al., 1995). In contrast, we previously identified an Ile-Arg-Ser CDR3 motif and conservation of
an 8-residue long CDR3 in CTL clones recognizing thedescribed a high frequency of influenza A/Texas virus
CTLp (1/3,600) in an individual with hemochromatosis M.57-68 epitope of the influenza matrix (Moss et al.,
1991), suggesting that this motif may play an important(HC12), from a 1989 PBMC sample (Bourgault et al.,
1989). In the present study, we show that this influenza- role in recognition of this particular HLA/peptide com-
plex. Interestingly, we found a similar motif including resi-specific CTLp frequency was stable over 5 years. This
result was confirmed with the use of molecular finger- dues Leu-Arg-Ala-Thr in the Vb17-Jb2.2 clone. This sug-
gests that Vb17-Jb2.2 cells were being selected eitherprinting in vivo, using a clonotypic primer corresponding
to the predominant virus matrix-specific CTL response. by the matrix epitope, or alternatively, by a very homoge-
neous cross-reactive epitope. The conserved Arg residueEven though the long term persistance of CTL popula-
tions in the absence of specific antigen is established, may also be the most important amino acid for the pep-
tide-HLA-A0201 recognition complex, insofar as it is en-memory CD8/ T cells directed against the influenza virus
tend to decline after 2–3 years in the absence of a new coded by different codons in different clones.
The single CDR3 nucleotide sequence of Vb17-Jb2.2encounter with the virus (McMichael et al., 1983). More-
over, the individual studied in this report, a 56-year-old molecular clones obtained, and the long-term mainte-
nance of the influenza-specific population detectable inman, has never been vaccinated against influenza and
has no recollection of any influenza symptoms. Thus, the the PBMC of donor HC12 with the specific clonotype,
may indicate that we stimulated a memory population.in vivo long-term maintenance of CTLp specific to the
M.58-66 peptide in this donor is probably not the result Indeed, continuous exposure in vivo to a repeatedly en-
countered human pathogen will activate and expandof an acute influenza infection.
Previous studies demonstrated biased usage of TCR memory T cells rather than trigger new clones of naive
cells and will favor clonal versus oligoclonal accumula-Vb17 and a very homogeneous CDR3b sequence in re-
sponse to the influenza matrix epitope in HLA-A0201 indi- tion of CD8/ memory subsets that occasionally result in
clonal dominance. Furthermore, recent studies sug-viduals. Despite skewing toward the expression of this
gene segment, Jb usage varied considerably (Lehner et gested (i) long-lived cytolytic T cell memory in the ab-
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Virus-specific CD8/ T-cell memory determined by clonal burst size.sence of antigen (Hou et al., 1994; Mullbacher, 1994),
Nature 369, 652–654.(ii) interactions with cross-reactive self-antigens, which
Jameson, S. C., and Bevan, M. J. (1995). T cell receptor antagonists and
could explain the maintenance of memory in vivo by par- partial agonists. Immunity 2, 1–11.
tial activation, as suggested for ‘‘partial agonists’’ (Jame- Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S., and Foeller, C.
(1991). ‘‘Sequences of proteins of immunological interest.’’, 3 (Fifthson and Bevan, 1995; Sloan-Lancaster and Allen, 1995),
Edition) Natl. Inst. Health. Bethesda, MD.and (iii) stability of the CTL memory response and periph-
Lau, L. L., Jamieson, B. D., Somasundaram, T., and Ahmed, R. (1994).eral localization of these memory populations (Lau et al., Cytotoxic T-cell memory without antigen. Nature 369, 648–652.
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